We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App




Innovative Approach Developed for Sampling Gut Bacteria

By LabMedica International staff writers
Posted on 04 Jun 2014
A new protocol for collecting saliva and stool samples for genomic and transcriptomic analyses has been developed which eliminates the need for specialized personnel and facilities while keeping the sample intact.

The protocol provides critical insight into the genetic makeup of the microbiome of the digestive tract and the bacteria associated with celiac disease, oral cancer, periodontitis, and obesity and this technique will enable both longitudinal studies and large collection studies that are not limited by geography.

Scientists at the Forsyth Institute (Cambridge, MA, USA) with colleagues from other institutes conducted one of the first human microbiome studies in a well-phenotyped prospective cohort incorporating taxonomic, metagenomic, and metatranscriptomic profiling at multiple body sites using self-collected samples. More...
Eight male subjects provided self-collected stool and saliva samples for shotgun metagenomic and metatranscriptomic sequencing.

To evaluate the effects of sample handling method on the assays, each stool sample was subdivided to produce three aliquots: a fresh frozen control sample, a sample fixed in ethanol, and a sample fixed in RNAlater (Qiagen; Valencia, CA, USA). From among the participants of a Health Professionals Follow-up Study, they selected 63 men who represented extremes of western versus prudent dietary intake and sent them kits for self-collection of saliva and stool at home. All DNA-based samples were then sequenced by Illumina HiSeq (San Diego, CA, USA), with each DNA sample run on a single sequencing lane, and each ribonucleic acid (RNA), (complementary DNA, cDNA) sample run on a pair of sequencing lanes.

The scientists found that within-subject microbial species, gene, and transcript abundances were highly concordant across sampling methods, with only a small fraction of transcripts less than 5%, displaying between-method variation. The team investigated relationships between the oral and gut microbial communities, identifying a subset of abundant oral microbes that routinely survive transit to the gut but have minimal transcriptional activity there. Systematic comparison of the gut metagenome and metatranscriptome revealed that a substantial fraction of 41% of microbial transcripts was not differentially regulated relative to their genomic abundances.

Jacques Izard, PhD, a coauthor of the study said, “We are excited about the opportunities this protocol presents for future large-scale studies. As the sensitivity of the sequencing technologies and the computing tools are improving, minute change can be detected. Our collaborative group demonstrated that we can analyze samples self-collected and shipped, in confidence for future biological marker discovery.” The study was published on May 19, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Forsyth Institute 
Qiagen 
Illumina 



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.